HealthCare Global Enterprises Ltd
Unaudited Financial Results of the Company for the quarter ended June 30, 2026.
RESULTS
▲ Positive Development
LOW RISK
📅 Filed on BSE: 06 Aug 2026, 07:14 PM IST · BSE ID: c75f06b7-062b-407f-a728-69c20beff3f2
View Original BSE Filing (PDF)
💡
In Simple Terms
HealthCare Global's board released its first quarter financial results, showing Rs. 37,525 Lakhs in revenue and Rs. 558 Lakhs profit.
🤖 AI Summary
- Board approved Q1 FY27 unaudited financial results for the quarter ended June 30, 2026.
- Consolidated revenue from operations was Rs. 37,525 Lakhs for Q1 FY27.
- Profit for the period stood at Rs. 558 Lakhs for the quarter ended June 30, 2026.
- Approved further investment of up to INR 16 Crore in HCG Rajkot Hospitals LLP.
- Completed divestment of BACC Healthcare Private Limited for Rs. 3,764 lakhs on June 29, 2026.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Revenue from operations (Q1 FY27)
37,525 Rs. in Lakhs
15.13
Profit for the period (Q1 FY27)
558 Rs. in Lakhs
61.74
Total income (Q1 FY27)
38,622 Rs. in Lakhs
15.28
Total expenses (Q1 FY27)
37,874 Rs. in Lakhs
14.84
Basic EPS (Q1 FY27)
0.37 Rs.
48.00
Investment in HCG Rajkot Hospitals LLP
up to 16 Crore INR
Divestment consideration for BACC Healthcare Private Limited
3,764 Lakhs Rs.
Acquisition cost for 34% equity in VHCRPL
15,450 Lakhs Rs.
🏢 How This Affects the Company
The company's revenue from operations increased to Rs. 37,525 Lakhs for the quarter ended June 30, 2026, compared to Rs. 32,593 Lakhs in the corresponding prior quarter. The divestment of BACC Healthcare Private Limited removes its infertility treatment business from the company's portfolio. The completion of acquiring an additional 34% equity in Vizag Hospital And Cancer Research Centre Private Limited (VHCRPL) increases ownership and operational control in that entity.
The company reported a profit for the period of Rs. 558 Lakhs, an increase from Rs. 345 Lakhs in the prior comparable quarter. The completed divestment of BACC Healthcare Private Limited for Rs. 3,764 lakhs generated cash, with Rs. 2,823 lakhs received upfront. The acquisition of additional 34% equity in VHCRPL for Rs. 15,450 lakhs utilized funds, fully deploying proceeds from the rights issue.
The continued investment in HCG Rajkot Hospitals LLP supports the expansion and operational capacity of that wholly-owned subsidiary. With the divestment of BACC, the company's operational focus shifts further towards oncology care.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders based on this financial results and operational update.
👤
Who Is Affected
All shareholders are affected by the improved financial performance and the strategic adjustments to the company's asset portfolio, including completed divestments and acquisitions.
🔍
Management Signal
Management is focused on consolidating its core oncology business, divesting non-core assets, and deploying capital for strategic acquisitions and subsidiary investments.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q2 FY27 unaudited financial results for sustained performance.
Updates on the HCG Employee Stock Option Scheme - 2026 implementation.
Further details on the utilization of the INR 16 Crore investment in HCG Rajkot Hospitals LLP.
LOW RISK
The financial results indicate operational improvements, and strategic corporate actions are completed as planned.
💡 Investor Takeaway
HealthCare Global Enterprises Ltd reported Q1 FY27 standalone revenue from operations of Rs. 37,525 Lakhs, an increase from Rs. 32,593 Lakhs YoY. Profit for the period rose to Rs. 558 Lakhs from Rs. 345 Lakhs. The company completed the divestment of BACC for Rs. 3,764 lakhs and acquired an additional 34% equity in VHCRPL for Rs. 15,450 lakhs.
⚖️ Strengths & Concerns
✅ Positives
- Revenue from operations increased by 15.13% to Rs. 37,525 Lakhs in Q1 FY27 from Rs. 32,593 Lakhs in Q1 FY26.
- Profit for the period grew to Rs. 558 Lakhs in Q1 FY27, compared to Rs. 345 Lakhs in Q1 FY26, a 61.74% increase.
⚠️ Concerns
- Total expenses for the quarter ended June 30, 2026, increased to Rs. 37,874 Lakhs from Rs. 32,979 Lakhs in the corresponding prior quarter.
- Finance costs remained high at Rs. 2,173 Lakhs for the current quarter, compared to Rs. 2,430 Lakhs in Q1 FY26.
📅 Company Track Record
In March 2026, HealthCare Global received board approval for investments into two profitable cancer subsidiaries, HCG NCHRI Oncology LLP and Vizag Hospital And Cancer Research Centre Private Limited (VHCRPL), deploying INR 253.66 Crore rights issue proceeds. This included achieving 85% ownership in Vizag and aiming for a debt-free NCHRI by Q1 FY27. The current filing confirms completion of the additional 34% acquisition in VHCRPL.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What was HealthCare Global's revenue from operations in Q1 FY27?
HealthCare Global's revenue from operations for the quarter ended June 30, 2026, was Rs. 37,525 Lakhs.
What was HealthCare Global's profit for the period in Q1 FY27?
HealthCare Global reported a profit for the period of Rs. 558 Lakhs for the quarter ended June 30, 2026.
What significant corporate actions did HealthCare Global complete in Q1 FY27?
HealthCare Global completed the divestment of BACC Healthcare Private Limited for Rs. 3,764 Lakhs and the acquisition of an additional 34% equity in VHCRPL for Rs. 15,450 Lakhs.
What was the year-on-year growth in HealthCare Global's revenue for Q1 FY27?
Revenue from operations increased by 15.13% to Rs. 37,525 Lakhs in Q1 FY27, up from Rs. 32,593 Lakhs in the corresponding quarter of Q1 FY26.
Questions based on this BSE filing only. For information purposes.